SLQT

MKT CAP:$161M

SelectQuote, Inc.

Market Cap

$161M

Financial Services·Insurance - Brokers·🇺🇸 United States·NYSE

Financials·Insurance·🇺🇸·NYSE

Stock Price

$0.91-$0.46 (-33.59%)

Apr 24, 2026

Company Details

SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance policies to consumers from various insurance carriers in the United States. The company operates through three segment...

CEO

Timothy Robert Danker

IPO Date

May 21, 2020

Website

www.selectquote.com

Key Metrics TTM

Revenue

$1.6B

+11.1% YoY

Net Income

$78M

EPS (Diluted)

$0.11

Free Cash Flow

$8M

Revenue / Share

$8.71

Gross Margin

59.5%

Operating Margin

2.7%

Net Margin

4.8%

FCF Margin

0.5%

P/S

0.1x

P/E

2.1x

Earnings Reports

Q3 2026

May 11, 2026

PENDING

Q2 2026

Feb 5, 2026

$537M+11.6%EPS $0.27

Q1 2026

Nov 6, 2025

$329M+12.5%EPS -$0.26

Q4 2025

Aug 21, 2025

$345M+12.3%EPS -$0.02

Q3 2025

May 12, 2025

$408M+8.4%EPS $0.12

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 22	$274M	$159M	$2M
Q4 22	$136M	$29M	-$122M
Q1 23	$162M	$55M	-$40M
Q2 23	$319M	$178M	$53M
Q3 23	$299M	$158M	$34M
Q4 23	$222M	$85M	-$36M
Q1 24	$233M	$76M	-$22M
Q2 24	$405M	$214M	$55M
Q3 24	$376M	$186M	$33M
Q4 24	$307M	$122M	-$1M
Q1 25	$292M	$97M	-$12M
Q2 25	$481M	$224M	$71M
Q3 25	$408M	$166M	$22M
Q4 25	$345M	$104M	-$13M
Q1 26	$329M	$67M	-$41M
Q2 26	$537M	$627M	$75M

Valuation

Quarter	P/S	P/E
Q3 22	0.2x	—
Q4 22	0.2x	—
Q1 23	0.2x	—
Q2 23	0.2x	—
Q3 23	0.2x	—
Q4 23	0.2x	—
Q1 24	0.1x	—
Q2 24	0.1x	—
Q3 24	0.1x	—
Q4 24	0.1x	—
Q1 25	0.1x	—
Q2 25	0.1x	—
Q3 25	0.1x	43.6x
Q4 25	0.1x	3.4x
Q1 26	0.1x	2.6x
Q2 26	0.1x	2.1x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 22	$21M	$12M
Q4 22	-$54M	-$57M
Q1 23	-$47M	-$50M
Q2 23	-$28M	-$30M
Q3 23	$63M	$60M
Q4 23	-$7M	-$9M
Q1 24	-$24M	-$26M
Q2 24	-$26M	-$29M
Q3 24	$44M	$43M
Q4 24	$19M	$19M
Q1 25	-$17M	-$19M
Q2 25	-$29M	-$31M
Q3 25	$71M	$70M
Q4 25	-$37M	-$38M
Q1 26	-$22M	-$26M
Q2 26	$52.0K	$2M

Capital Expenditures

Quarter	CapEx
Q3 22	$9M
Q4 22	$3M
Q1 23	$2M
Q2 23	$2M
Q3 23	$2M
Q4 23	$2M
Q1 24	$2M
Q2 24	$4M
Q3 24	$1M
Q4 24	$268.0K
Q1 25	$3M
Q2 25	$2M
Q3 25	$949.0K
Q4 25	$501.0K
Q1 26	$4M
Q2 26	$2M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 22	+3.4%	+28.2%
Q4 22	-27.6%	+47.9%
Q1 23	+4.1%	-4.8%
Q2 23	+64.3%	-27.7%
Q3 23	+9.1%	-2.3%
Q4 23	+62.6%	-0.2%
Q1 24	+43.2%	+26.3%
Q2 24	+27.0%	+31.6%
Q3 24	+25.7%	+29.2%
Q4 24	+38.5%	+19.9%
Q1 25	+25.6%	+19.2%
Q2 25	+18.7%	+17.1%
Q3 25	+8.4%	+12.5%
Q4 25	+12.3%	+15.9%
Q1 26	+12.5%	+21.5%
Q2 26	+11.6%	+12.6%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 22	$2M	0.8%
Q4 22	$800.0K	0.6%
Q1 23	$3M	1.6%
Q2 23	$3M	0.9%
Q3 23	$3M	1.0%
Q4 23	$3M	1.3%
Q1 24	$3M	1.4%
Q2 24	$4M	0.9%
Q3 24	$0	0.0%
Q4 24	$0	0.0%
Q1 25	$4M	1.3%
Q2 25	$5M	1.0%
Q3 25	$5M	1.2%
Q4 25	$5M	1.4%
Q1 26	$4M	1.3%
Q2 26	$3M	0.6%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q3 22	$6M	$25M	$125M
Q4 22	$6M	$25M	$75M
Q1 23	$6M	$31M	$58M
Q2 23	$6M	$28M	$90M
Q3 23	$6M	$28M	$90M
Q4 23	$7M	$50M	$64M
Q1 24	$8M	$29M	$62M
Q2 24	$8M	$33M	$117M
Q3 24	$9M	$35M	$109M
Q4 24	$9M	$44M	$70M
Q1 25	$9M	$36M	$64M
Q2 25	$10M	$45M	$98M
Q3 25	—	$42M	$93M
Q4 25	—	—	$230M
Q1 26	$10M	$36M	$62M
Q2 26	$10M	$36M	$107M

Revenue Segments

Quarter	Pharmacy	Product and Service, Other	Service
Q1 24	$95M	$20M	$118M
Q2 24	$109M	$33M	$263M
Q3 24	$120M	$25M	$231M
Q1 25	$153M	$998.0K	$139M
Q2 25	$180M	$861.0K	$301M
Q3 25	$185M	$1M	$223M
Q4 25	$211M	$1M	$135M
Q1 26	$219M	$1M	$110M
Q2 26	$227M	$1M	$310M

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 22	$199M	$0	$199M
Q4 22	$141M	$0	$141M
Q1 23	$71M	$0	$71M
Q2 23	$36M	$0	$36M
Q3 23	$92M	$0	$92M
Q4 23	$83M	$0	$83M
Q1 24	$48M	$0	$48M
Q2 24	$11M	$0	$11M
Q3 24	$38M	$0	$38M
Q4 24	$43M	$0	$43M
Q1 25	$10M	$0	$10M
Q2 25	$12M	$0	$12M
Q3 25	$80M	$0	$80M
Q4 25	$32M	$0	$32M
Q1 26	$11M	$0	$11M
Q2 26	$22M	$0	$22M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 22	164M	+0.1%	-1.0%
Q4 22	164M	+0.2%	-0.8%
Q1 23	165M	+0.2%	+0.7%
Q2 23	167M	+1.0%	+1.6%
Q3 23	168M	+0.8%	+2.3%
Q4 23	167M	-0.7%	+1.4%
Q1 24	167M	+0.4%	+1.6%
Q2 24	170M	+1.4%	+1.9%
Q3 24	171M	+0.7%	+1.8%
Q4 24	169M	-1.4%	+1.1%
Q1 25	170M	+1.1%	+1.8%
Q2 25	170M	0.0%	+0.4%
Q3 25	170M	0.0%	-0.3%
Q4 25	184M	+8.1%	+9.3%
Q1 26	186M	+0.9%	+9.0%
Q2 26	186M	0.0%	+9.0%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 22	$202.3K	1K
Q4 22	$73.5K	2K
Q1 23	$87.5K	2K
Q2 23	$171.9K	2K
Q3 23	$161.2K	2K
Q4 23	$109.0K	2K
Q1 24	$114.4K	2K
Q2 24	$199.2K	2K
Q3 24	$185.0K	2K
Q4 24	$71.6K	4K
Q1 25	$68.1K	4K
Q2 25	$112.1K	4K
Q3 25	$95.1K	4K
Q4 25	$292.2K	1K
Q1 26	$278.4K	1K
Q2 26	$454.8K	1K

Revenue / Employee